SysGene Biologics
Developing biologics faster, powered by patented platform technologies & deep bioprocess expertise
Founded in 2026, SysGene Biologics is guided by a simple belief: essential biologics should be more accessible and affordable. We bring together biologics expertise, enabling manufacturing technologies and focused bioprocess solutions to help manufacturers address production challenges, improve efficiency and reduce costs while maintaining quality.
Molecule first
The molecule determines the route, not a one-size-fits-all process.
Every program begins with the molecule’s structure, function and quality requirements, ensuring that the most appropriate platform and development strategy are selected.
Two platform routes
Platform selection follows the molecule
Bacterial secretion
Patented Bacterial Secretion Platform
Designed to produce suitable recombinant proteins and peptides directly into the culture medium. For compatible molecules, extracellular secretion can simplify recovery by reducing reliance on cell lysis, inclusion-body isolation, solubilization and refolding.
Mammalian expression
Patented Mammalian Expression Platform
A CHO-based platform for complex and glycosylated biologics that require mammalian folding, assembly and post-translational processing.
Capabilities
From sequence to a documented, transferable process
Expression, upstream development, recovery, purification, analytical characterization, scale-up and technology transfer, planned around defined program goals.
Feasibility
Assess molecule fit and define the target quality profile.
Expression strategy
Select the platform route and development mode.
Upstream development
Host/cell-line, media, feed and process-mode work.
Downstream & analytics
Recovery, purification and characterization.
Scale-up & transfer
Documented, transfer-ready process package.
Manufacture
Analytical and method development, with 5 L mammalian and 30–1,000 L microbial capacity; 5,000 L planned.
Quality & Company
Quality built into development and supply
Development and characterization are aligned with ICH guidelines, and every product is manufactured to the requirements of its stated grade, research grade, multi-compendial or GMP.
Discuss your molecule or product requirement
Tell us what you are developing or sourcing and we will route your enquiry to the right technical and business team.
Contact SysGene